Scientific discoveries in physics help doctors improve the treatment experience.
Roslyn and Leonard Stoler cut the ribbon celebrating the opening of the Department of Radiation Oncology's Program of Excellence in Technology Translational Research. The Stolers are major supporters of the University of Maryland Marlene and Stewart Greenebaum Cancer Center. (See Press Release)
August, 2007: Physicians and scientists at the University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) are pursuing a powerful vision for the development of a technology-based Program of Excellence in the Department of Radiation Oncology. The goal of the program is vastly improved medical care for cancer patients, higher cure rates and the promise of hope for all who face the challenge of this disease.
Experts in the Department of Radiation Oncology have a track record of innovation and have developed some of the field’s most advanced techniques for improving the effectiveness and safety of radiation treatment. Such innovations as Intensity Modulated Radiation Therapy (IMRT), Direct Aperture Optimization (DAO), and Intensity Modulated Arc Therapy (IMAT) were all developed or perfected by medical physicists at Maryland.
Building on this success, the new Program of Excellence in Technology Translational Research is poised to move these efforts dramatically forward, thanks to the convergence of several key factors: an outstanding medical physics team, state-of-the-art Trilogy technology, and a unique research partnership with the world’s leading radiation therapy technology company.
In 2006 the department became the first academic center in the region to offer Trilogy, the latest stereotactic radiation technology for treating patients with cancer. The department is also one of only four academic centers in the country to have a Master Research Agreement with Varian Medical Systems to develop new radiation technologies.
As part of the new Program of Excellence, the department has added a dedicated research linear accelerator, which will dramatically increase research productivity, both for medical physicists and clinical faculty.
“What’s exciting about this initiative is that for the first time we will have research and development taking place right alongside the clinic in real time. Not only do we have the most sophisticated technology available -- a state-of-the-art linear accelerator dedicated solely to scientific research -- but now we will be able to translate our discoveries directly into patient care faster than ever before,” notes Mohan Suntha, M.D., director of the Program of Excellence.
Research efforts within the new Program of Excellence will focus on improved approaches to targeting tumors and on the development of new treatment planning and delivery systems.
For more information about the Program of Excellence in Technology Translational Research, or ongoing patient care and research activities, please contact the Department of Radiation Oncology at 410-328-6080.